D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Tesla
TSLA
|
+$765M |
| 2 |
Baidu
BIDU
|
+$627M |
| 3 |
Coca-Cola
KO
|
+$444M |
| 4 |
NVIDIA
NVDA
|
+$380M |
| 5 |
Tencent Music
TME
|
+$344M |
Top Sells
| 1 |
Amazon
AMZN
|
+$957M |
| 2 |
Wells Fargo
WFC
|
+$743M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$604M |
| 4 |
GameStop
GME
|
+$532M |
| 5 |
DuPont de Nemours
DD
|
+$420M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Consumer Discretionary | 13.32% |
| 3 | Healthcare | 10.88% |
| 4 | Communication Services | 10.66% |
| 5 | Financials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Digimarc
DMRC
$198M
| $10.1M | 0.01% |
339,116
+60,933
| +22% | +$1.81M |
|
902
Exelixis
EXEL
$10.5B
| $10M | 0.01% |
444,347
-27,259
| -6% | -$616K |
|
903
Carpenter Technology
CRS
$12.1B
| $10M | 0.01% |
243,710
-151,925
| -38% | -$6.25M |
|
904
Weibo
WB
$2.92B
| $9.95M | 0.01% |
+197,175
| New | +$9.95M |
|
|
ERF
905
DELISTED
Enerplus Corporation
ERF
| $9.94M | 0.01% |
1,978,884
+909,600
| +85% | +$4.57M |
|
906
RB Global
RBA
$22B
| $9.93M | 0.01% |
169,602
-77,813
| -31% | -$4.56M |
|
|
XLRN
907
DELISTED
Acceleron Pharma Inc.
XLRN
| $9.92M | 0.01% |
73,175
+11,226
| +18% | +$1.52M |
|
908
MaxLinear
MXL
$1.4B
| $9.89M | 0.01% |
290,161
-463,151
| -61% | -$15.8M |
|
909
Capri Holdings
CPRI
$2.6B
| $9.89M | 0.01% |
+193,837
| New | +$9.89M |
|
|
DISAU
910
DELISTED
Disruptive Acquisition Corporation I Unit
DISAU
| $9.88M | 0.01% |
+1,000,000
| New | +$9.88M |
|
911
Synopsys
SNPS
$81.4B
| $9.87M | 0.01% |
+39,836
| New | +$9.87M |
|
912
Fastly
FSLY
$1.16B
| $9.83M | 0.01% |
146,043
-430,541
| -75% | -$29M |
|
913
Kura Oncology
KURA
$766M
| $9.82M | 0.01% |
347,190
-233,403
| -40% | -$6.6M |
|
914
Veracyte
VCYT
$2.51B
| $9.82M | 0.01% |
182,604
+153,978
| +538% | +$8.28M |
|
915
Atara Biotherapeutics
ATRA
$85.8M
| $9.81M | 0.01% |
27,322
+2,936
| +12% | +$1.05M |
|
|
SV
916
DELISTED
Spring Valley Acquisition Corp. Class A Ordinary Share
SV
| $9.8M | 0.01% |
+969,721
| New | +$9.8M |
|
917
Regeneron Pharmaceuticals
REGN
$60.2B
| $9.79M | 0.01% |
20,700
-34,958
| -63% | -$16.5M |
|
918
LivePerson
LPSN
$91.8M
| $9.78M | 0.01% |
185,377
+160,029
| +631% | +$8.44M |
|
919
Sotera Health
SHC
$4.58B
| $9.77M | 0.01% |
391,237
+351,650
| +888% | +$8.78M |
|
920
Cheniere Energy
LNG
$52.1B
| $9.76M | 0.01% |
135,472
+122,582
| +951% | +$8.83M |
|
921
TrueCar
TRUE
$199M
| $9.67M | 0.01% |
2,020,253
+107,965
| +6% | +$517K |
|
922
Westlake Corp
WLK
$11.5B
| $9.66M | 0.01% |
108,756
+50,495
| +87% | +$4.48M |
|
923
Bank of Montreal
BMO
$90.8B
| $9.59M | 0.01% |
+107,500
| New | +$9.59M |
|
924
D.R. Horton
DHI
$54B
| $9.58M | 0.01% |
107,535
-108,539
| -50% | -$9.67M |
|
|
TCS
925
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $9.58M | 0.01% |
38,360
+2,486
| +7% | +$621K |
|